In this episode, Dr. Paul Wheatley-Price chats with Dr. Betinna Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada.
Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/
All content for Lung Cancer Voices is the property of Lung Cancer Canada and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, Dr. Paul Wheatley-Price chats with Dr. Betinna Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada.
Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/
Ep 104. Microbiome, Gut Health & Cancer w/ Dr. Arielle Elkrief
Lung Cancer Voices
37 minutes 37 seconds
3 weeks ago
Ep 104. Microbiome, Gut Health & Cancer w/ Dr. Arielle Elkrief
In this episode, Dr. Paul Wheatley-Price chats with Dr. Arielle Elkrief, Medical Oncologist, Co-Director of the CHUM Microbiome Center, and Clinician-Scientist at the University of Montreal. They discuss everything about the microbiome and gut health - what is the microbiome, why it's important in cancer and treatments, tips for a healthy microbiome, antibiotics, and even "poop pills".
Lung Cancer Voices
In this episode, Dr. Paul Wheatley-Price chats with Dr. Betinna Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada.
Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/